0.644

0.62% -0.004

Cypherpunk Technologies Inc (CYPH)

Overview News Price History Discussions Forecast

Cypherpunk Technologies Inc stock is traded at $0.644, with a volume of 561.96K. It is down -0.62% in the last 24 hours and down -12.00% over the past month. Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Previous Close:

$0.648

Open:

$0.6492

24h Volume:

561.96K

Relative Volume:

0.15

Market Cap:

$69.40M

Revenue:

Net Income/Loss:

$-56.91M

P/E Ratio:

-37.44

EPS:

-0.0172

Net Cash Flow:

$-133.85M

1W Performance:

-6.48%

1M Performance:

-12.00%

6M Performance:

-9.28%

1Y Performance:

+0.00%

1-Day Range:

$0.6231

$0.6572

1-Week Range:

$0.622

$0.72

52-Week Range:

$0.4913

$3.6999

Cypherpunk Technologies Inc Stock (CYPH) Company Profile

Name

Cypherpunk Technologies Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

617 252 4343

Address

47 THORNDIKE STREET, CAMBRIDGE

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

CYPH's Discussions on Twitter

Compare CYPH vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CYPH Cypherpunk Technologies Inc	0.644	70.90M	0	-56.91M	-133.85M	-0.0172
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Cypherpunk Technologies Inc Stock (CYPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-29-25	Downgrade	H.C. Wainwright	Buy → Neutral
Jan-29-25	Downgrade	Robert W. Baird	Outperform → Neutral
Jun-28-24	Initiated	Rodman & Renshaw	Buy
Oct-04-21	Initiated	Mizuho	Buy
Jun-04-21	Resumed	Robert W. Baird	Outperform
Jun-29-20	Initiated	Piper Sandler	Overweight
Feb-11-20	Initiated	Robert W. Baird	Outperform
Nov-15-19	Downgrade	Raymond James	Outperform → Mkt Perform
Sep-13-19	Resumed	Raymond James	Outperform
Mar-07-17	Initiated	Ladenburg Thalmann	Buy

View All

Cypherpunk Technologies Inc Stock (CYPH) Latest News

Aug 13, 2026

Cypherpunk Reports $39.4 Million Q2 Net Income as ZEC Holdings Rise - Moomoo

Aug 13, 2026

Cypherpunk Technologies Inc. (NASDAQ: CYPH) Share Price, CYPH Stock News, CYPH Share Price & Updates - Kalkine

Aug 13, 2026

Cypherpunk Technologies Inc (CYPH)

Cypherpunk Technologies Inc Stock (CYPH) Company Profile

Compare CYPH vs VRTX, REGN, ARGX, RVMD, ONC

Cypherpunk Technologies Inc Stock (CYPH) Upgrades & Downgrades

Cypherpunk Technologies Inc Stock (CYPH) Latest News

Cypherpunk Reports $39.4 Million Q2 Net Income as ZEC Holdings Rise - Moomoo

Cypherpunk Technologies Inc. (NASDAQ: CYPH) Share Price, CYPH Stock News, CYPH Share Price & Updates - Kalkine

Is Zcash price gearing up for a rally above $500? - TradingView

Cypherpunk Technologies Releases Q2 2026 Financial Results - AlphaStreet

Cypherpunk Technologies swings to $39M Q2 profi... - pluang.com

Form 8K Cypherpunk Technologies Inc For: 12 August By Investing.com - Investing.com South Africa

Is Cypherpunk Technologies Inc (CYPH) on a Path to Recovery Afte - GuruFocus

Form 8K Cypherpunk Technologies Inc For: 12 August - Investing.com India

CYPHERPUNK TECHNOLOGIES INC. 2026: Revenue $39.39M, EPS $0.18— 10-Q Summary - TradingView

Leap Therapeutics publishes DeFianCe trial results in journal By Investing.com - Investing.com Canada

Leap Therapeutics publishes DeFianCe trial results in journal - Investing.com

Cypherpunk Technologies (CYPH) swings to $39.4M profit on volatile Zcash gains - Stock Titan

Cypherpunk Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Cypherpunk Technologies (CYPH) swings to Q2 profit on $46M Zcash gain and biotech progress - Stock Titan

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results - PR Newswire

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research - PR Newswire

Cypherpunk Technologies (NASDAQ:CYPH) Stock Crosses Below Fifty Day Moving AverageHere's What Happened - MarketBeat

Cypherpunk Technologies Inc expected to post a loss of 3 cents a shareEarnings Preview - TradingView

Cypherpunk Technologies (CYPH) Slides 8% as Shares Approach Critical $0.64 SupportOBV Divergence - dars.gov.et

Cypherpunk Technologies Ord Shs (CYPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com

Cypherpunk Technologies (NASDAQ:CYPH) Stock Passes Below 50 Day Moving AverageHere's What Happened - MarketBeat

Cypherpunk Technologies Inc. (CYPH) Q3 2025 Earnings: EPS Surprise of 67.32% Despite Net LossEarnings Sentiment Score - dars.gov.et

Cypherpunk Technologies Inc. Revenue Breakdown – NASDAQ:CYPH - TradingView

Cypherpunk Technologies (NASDAQ:CYPH) Stock Price Up 0.9%Time to Buy? - MarketBeat

Cypherpunk Technologies Ord Shs (CYPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Cypherpunk Technologies Ord Shs (CYPH) Institutional Confidence - TradingKey

Cypherpunk Technologies Inc. (CYPH) Q3 2025 Earnings: Narrowed Loss Beats Expectations, Yet Stock SlidesSegment Revenue Breakdown - dars.gov.et

Cypherpunk Technologies Faces Nasdaq Listing Compliance Warning - The Globe and Mail

Cypherpunk Technologies Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Nasdaq warns Cypherpunk Technologies (Nasdaq: CYPH) on $1 bid rule - Stock Titan

CYPH Q3 2025 Earnings: EPS Surprise of 67% Drives Stock Higher Amid Slimmer-Than-Expected LossEarnings Outlook Update - dars.gov.et

Price to earnings forward of Cypherpunk Technologies Inc. – MUN:5MC - TradingView

Enterprise value to EBITDA forward of Cypherpunk Technologies Inc. – NASDAQ:CYPH - TradingView

Cypherpunk Technologies(CYPH) Stock Options Chain | Quotes & News - Moomoo

Cypherpunk Technologies (CYPH) Holds Near Support After Marginal DeclineWyckoff Accumulation - po-news-eg.net

These stocks are moving in today's after hours session - ChartMill

CYPH Q3 2025 Earnings: Narrowed Loss Exceeds Expectations, Shares RiseRetail Earnings Report - dars.gov.et

Cypherpunk Technologies Inc Stock Historical Valuations | HAM:5MC - GuruFocus

Cypherpunk Technologies Inc (HAM:5MC) Valuation - GuruFocus

Cypherpunk Technologies Inc Stock Warning Signs | HAM:5MC - GuruFocus

Cypherpunk Technologies Inc Stock Operating Data - GuruFocus

Cypherpunk Technologies Inc (HAM:5MC) Stock Earnings Transcripts - GuruFocus

Enterprise value to revenue forward of Cypherpunk Technologies Inc. – NASDAQ:CYPH - TradingView

Enterprise value to revenue forward of Cypherpunk Technologies Inc. – HAM:5MC - TradingView

Enterprise value to EBIT forward of Cypherpunk Technologies Inc. – NASDAQ:CYPH - TradingView

Price to earnings forward of Cypherpunk Technologies Inc. – DUS:5MC - TradingView

Price to book forward of Cypherpunk Technologies Inc. – NASDAQ:CYPH - TradingView

CYPH Q3 2025 Earnings: EPS Beats Estimates Amid Stealth GrowthEPS Estimate Trend - dars.gov.et

If You Invested $1,000 in Cypherpunk Technologies Inc (CYPH) - Stock Titan

CYPHCypherpunk Technologies Inc Volatility & Greeks - Finviz

CYPH Should I Buy - Intellectia AI

Cypherpunk Technologies Inc Stock (CYPH) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to CYPH